APP and Alzheimer disease: Since the Bielschowsky silver staining and immunostaining results suggested that PLGA-PEG-B6/Cur nanoparticles potentially reduced AD pathology in APP/PS1 mice, we further evaluated the Aβ-related proteins and p-tau protein level in mouse brain.